Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4I0P5
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0030488 | tRNA methylation | 5 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0005488 | binding | 1 | 13 |
GO:0008168 | methyltransferase activity | 4 | 13 |
GO:0008171 | O-methyltransferase activity | 5 | 13 |
GO:0008173 | RNA methyltransferase activity | 4 | 13 |
GO:0008175 | tRNA methyltransferase activity | 5 | 13 |
GO:0016740 | transferase activity | 2 | 13 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 13 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 5 | 13 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 6 | 13 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 13 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 13 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.404 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 262 | 264 | PF00675 | 0.626 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.462 |
CLV_NRD_NRD_1 | 331 | 333 | PF00675 | 0.303 |
CLV_PCSK_FUR_1 | 260 | 264 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.626 |
CLV_PCSK_KEX2_1 | 331 | 333 | PF00082 | 0.304 |
CLV_PCSK_PC7_1 | 327 | 333 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 327 | 331 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.358 |
CLV_Separin_Metazoa | 252 | 256 | PF03568 | 0.554 |
CLV_Separin_Metazoa | 373 | 377 | PF03568 | 0.604 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.536 |
DEG_SCF_FBW7_1 | 352 | 359 | PF00400 | 0.479 |
DOC_CKS1_1 | 353 | 358 | PF01111 | 0.479 |
DOC_PP1_RVXF_1 | 342 | 349 | PF00149 | 0.604 |
DOC_PP1_RVXF_1 | 477 | 483 | PF00149 | 0.448 |
DOC_PP2B_LxvP_1 | 178 | 181 | PF13499 | 0.496 |
DOC_PP2B_PxIxI_1 | 384 | 390 | PF00149 | 0.558 |
DOC_PP4_FxxP_1 | 140 | 143 | PF00568 | 0.407 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.381 |
DOC_USP7_MATH_1 | 210 | 214 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 308 | 312 | PF00917 | 0.443 |
DOC_USP7_MATH_1 | 380 | 384 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 448 | 452 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 473 | 477 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.632 |
DOC_WW_Pin1_4 | 141 | 146 | PF00397 | 0.443 |
DOC_WW_Pin1_4 | 352 | 357 | PF00397 | 0.527 |
DOC_WW_Pin1_4 | 498 | 503 | PF00397 | 0.488 |
LIG_14-3-3_CanoR_1 | 113 | 122 | PF00244 | 0.555 |
LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.474 |
LIG_14-3-3_CanoR_1 | 206 | 210 | PF00244 | 0.531 |
LIG_14-3-3_CanoR_1 | 331 | 337 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 347 | 353 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 426 | 434 | PF00244 | 0.570 |
LIG_14-3-3_CanoR_1 | 458 | 464 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 9 | 15 | PF00244 | 0.488 |
LIG_Actin_WH2_2 | 241 | 257 | PF00022 | 0.502 |
LIG_AP2alpha_2 | 304 | 306 | PF02296 | 0.404 |
LIG_APCC_ABBA_1 | 340 | 345 | PF00400 | 0.583 |
LIG_BIR_III_2 | 350 | 354 | PF00653 | 0.604 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.377 |
LIG_FHA_1 | 142 | 148 | PF00498 | 0.487 |
LIG_FHA_1 | 151 | 157 | PF00498 | 0.504 |
LIG_FHA_1 | 159 | 165 | PF00498 | 0.513 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.453 |
LIG_FHA_1 | 337 | 343 | PF00498 | 0.583 |
LIG_FHA_1 | 357 | 363 | PF00498 | 0.395 |
LIG_FHA_2 | 400 | 406 | PF00498 | 0.479 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.545 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.542 |
LIG_KLC1_Yacidic_2 | 401 | 405 | PF13176 | 0.479 |
LIG_LIR_Apic_2 | 137 | 143 | PF02991 | 0.429 |
LIG_LIR_Apic_2 | 401 | 406 | PF02991 | 0.461 |
LIG_LIR_Gen_1 | 220 | 228 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 220 | 224 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 226 | 231 | PF02991 | 0.435 |
LIG_MYND_1 | 316 | 320 | PF01753 | 0.479 |
LIG_PCNA_TLS_4 | 397 | 404 | PF02747 | 0.479 |
LIG_Pex14_1 | 16 | 20 | PF04695 | 0.347 |
LIG_RPA_C_Fungi | 24 | 36 | PF08784 | 0.358 |
LIG_SH2_CRK | 11 | 15 | PF00017 | 0.421 |
LIG_SH2_PTP2 | 403 | 406 | PF00017 | 0.291 |
LIG_SH2_SRC | 403 | 406 | PF00017 | 0.393 |
LIG_SH2_STAP1 | 160 | 164 | PF00017 | 0.415 |
LIG_SH2_STAP1 | 228 | 232 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.392 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 228 | 231 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 403 | 406 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 459 | 462 | PF00017 | 0.262 |
LIG_SH2_STAT5 | 488 | 491 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 495 | 498 | PF00017 | 0.323 |
LIG_SH3_2 | 353 | 358 | PF14604 | 0.495 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.630 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.349 |
LIG_SH3_3 | 299 | 305 | PF00018 | 0.377 |
LIG_SH3_3 | 350 | 356 | PF00018 | 0.495 |
LIG_SH3_3 | 386 | 392 | PF00018 | 0.342 |
LIG_SH3_3 | 458 | 464 | PF00018 | 0.320 |
LIG_SUMO_SIM_anti_2 | 144 | 150 | PF11976 | 0.295 |
LIG_SUMO_SIM_par_1 | 223 | 230 | PF11976 | 0.433 |
LIG_WRC_WIRS_1 | 228 | 233 | PF05994 | 0.526 |
LIG_WRC_WIRS_1 | 78 | 83 | PF05994 | 0.493 |
MOD_CDK_SPK_2 | 498 | 503 | PF00069 | 0.333 |
MOD_CDK_SPxK_1 | 352 | 358 | PF00069 | 0.320 |
MOD_CDK_SPxxK_3 | 498 | 505 | PF00069 | 0.369 |
MOD_CK1_1 | 396 | 402 | PF00069 | 0.307 |
MOD_CK1_1 | 453 | 459 | PF00069 | 0.346 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.617 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.488 |
MOD_CK2_1 | 459 | 465 | PF00069 | 0.404 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.470 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.538 |
MOD_GlcNHglycan | 368 | 371 | PF01048 | 0.495 |
MOD_GlcNHglycan | 409 | 412 | PF01048 | 0.373 |
MOD_GlcNHglycan | 416 | 419 | PF01048 | 0.362 |
MOD_GlcNHglycan | 443 | 446 | PF01048 | 0.368 |
MOD_GlcNHglycan | 448 | 451 | PF01048 | 0.376 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.605 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.507 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.438 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.175 |
MOD_GSK3_1 | 446 | 453 | PF00069 | 0.333 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.586 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.464 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.521 |
MOD_N-GLC_1 | 430 | 435 | PF02516 | 0.362 |
MOD_N-GLC_2 | 49 | 51 | PF02516 | 0.593 |
MOD_N-GLC_2 | 504 | 506 | PF02516 | 0.466 |
MOD_NEK2_1 | 227 | 232 | PF00069 | 0.517 |
MOD_NEK2_1 | 336 | 341 | PF00069 | 0.495 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.342 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.425 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.453 |
MOD_NEK2_2 | 152 | 157 | PF00069 | 0.382 |
MOD_NEK2_2 | 430 | 435 | PF00069 | 0.424 |
MOD_PIKK_1 | 114 | 120 | PF00454 | 0.437 |
MOD_PIKK_1 | 473 | 479 | PF00454 | 0.320 |
MOD_PIKK_1 | 80 | 86 | PF00454 | 0.452 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.440 |
MOD_PKA_2 | 205 | 211 | PF00069 | 0.611 |
MOD_PKA_2 | 254 | 260 | PF00069 | 0.566 |
MOD_PKA_2 | 346 | 352 | PF00069 | 0.412 |
MOD_PKA_2 | 425 | 431 | PF00069 | 0.375 |
MOD_PKB_1 | 325 | 333 | PF00069 | 0.431 |
MOD_Plk_1 | 204 | 210 | PF00069 | 0.691 |
MOD_Plk_1 | 233 | 239 | PF00069 | 0.464 |
MOD_Plk_1 | 430 | 436 | PF00069 | 0.439 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.496 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.384 |
MOD_Plk_4 | 297 | 303 | PF00069 | 0.379 |
MOD_Plk_4 | 399 | 405 | PF00069 | 0.320 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.540 |
MOD_ProDKin_1 | 141 | 147 | PF00069 | 0.437 |
MOD_ProDKin_1 | 352 | 358 | PF00069 | 0.388 |
MOD_ProDKin_1 | 498 | 504 | PF00069 | 0.333 |
TRG_DiLeu_BaEn_1 | 220 | 225 | PF01217 | 0.479 |
TRG_DiLeu_BaEn_1 | 63 | 68 | PF01217 | 0.462 |
TRG_DiLeu_BaLyEn_6 | 142 | 147 | PF01217 | 0.382 |
TRG_DiLeu_LyEn_5 | 220 | 225 | PF01217 | 0.479 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.371 |
TRG_ER_diArg_1 | 192 | 194 | PF00400 | 0.518 |
TRG_ER_diArg_1 | 260 | 263 | PF00400 | 0.600 |
TRG_ER_diArg_1 | 325 | 328 | PF00400 | 0.345 |
TRG_ER_diArg_1 | 331 | 334 | PF00400 | 0.342 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.448 |
TRG_Pf-PMV_PEXEL_1 | 376 | 381 | PF00026 | 0.431 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NJE0 | Trypanosomatidae | 32% | 100% |
A0A3Q8IG18 | Leishmania donovani | 53% | 100% |
A0A3S7WY71 | Leishmania donovani | 100% | 100% |
A4I0P4 | Leishmania infantum | 53% | 94% |
D0A723 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AIR1 | Leishmania braziliensis | 78% | 100% |
E9AWP4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 52% | 94% |
E9AWP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QAS6 | Leishmania major | 93% | 100% |
Q4QAS7 | Leishmania major | 52% | 94% |
V5BR90 | Trypanosoma cruzi | 35% | 97% |